This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.68% per year. These returns cover a period from January 1, 1988 through August 5, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Headquartered in Teaneck, NJ, Cognizant Technology Solutions Corporation is a leading professional services company. The company was spun off from Dun & Bradstreet in 1996 and went public in 1998. Cognizant’s services include digital services and solutions, consulting, application development, systems integration, application testing, application maintenance, infrastructure services, and business process services. Cognizant reported revenues of $16.78 billion in 2019. Revenues from clients added during 2019, including those related to acquisitions were $234 million.
Is First Trust Technology AlphaDEX ETF (FXL) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for FXL
Cognizant (CTSH) to Report Q3 Earnings: What's in Store?
by Zacks Equity Research
Cognizant's (CTSH) third-quarter 2023 performance is expected to have reflected growing domain expertise in its healthcare business operations.
Cognizant (CTSH) Expected to Beat Earnings Estimates: Should You Buy?
by Zacks Equity Research
Cognizant (CTSH) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Will Cognizant (CTSH) Beat Estimates Again in Its Next Earnings Report?
by Zacks Equity Research
Cognizant (CTSH) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Bel Fuse (BELFB) to Report Q3 Earnings: What's in the Cards?
by Zacks Equity Research
Bel Fuse's (BELFB) third-quarter 2023 performance will likely reflect gains from an expanding product portfolio, increasing end-customer demand and a favorable product mix.
CTSH vs. WIT: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
CTSH vs. WIT: Which Stock Is the Better Value Option?
Cognizant (CTSH) Boosts AI Prospects with Vianai Partnership
by Zacks Equity Research
Cognizant (CTSH) and Vianai unite to revolutionize AI with hila Enterprise and Neuro AI, delivering human-centered generative AI worldwide.
CoStar Group (CSGP) to Post Q3 Earnings: What's in Store?
by Zacks Equity Research
CoStar Group's (CSGP) third-quarter 2023 top line is likely to benefit from strong Apartments.com traffic and higher ad spending.
Is SPDR Russell 1000 Low Volatility Focus ETF (ONEV) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for ONEV
CTSH or WIT: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
CTSH vs. WIT: Which Stock Is the Better Value Option?
Cognizant (CTSH) Up 1.6% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
Cognizant (CTSH) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Cognizant (CTSH) Q2 Earnings Beat Estimates, Revenues Down Y/Y
by Zacks Equity Research
Cognizant's (CTSH) second-quarter 2023 results benefit from strong Health Sciences revenues and acquisitions amid a challenging macro environment.
Cognizant (CTSH) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
by Zacks Equity Research
While the top- and bottom-line numbers for Cognizant (CTSH) give a sense of how the business performed in the quarter ended June 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Cognizant (CTSH) Surpasses Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Cognizant (CTSH) delivered earnings and revenue surprises of 13.40% and 1.50%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
Cognizant (CTSH) to Report Q2 Earnings: What's in Store?
by Zacks Equity Research
Despite challenging macroeconomic conditions, Cognizant's (CTSH) second-quarter 2023 performance is expected to reflect growing domain expertise in its healthcare business operations.
Tyler Technologies (TYL) Tops Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Tyler Technologies (TYL) delivered earnings and revenue surprises of 8.06% and 2.78%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
Asure Software (ASUR) Partners With AWS Application Modernization
by Zacks Equity Research
Asure Software (ASUR) partners with Amazon Web Services Application Modernization Lab to leverage a distinct development framework to enhance its HCM Software as a Service offerings.
Cognizant (CTSH) Boosts AI-Driven Automation With ServiceNow
by Zacks Equity Research
Cognizant's (CTSH) strategic partnership with ServiceNow enables enterprises to adopt AI-driven automation and optimize operations, thereby enhancing end user experience.
Progress Software (PRGS) to Post Q2 Earnings: What's in Store?
by Zacks Equity Research
Progress Software's (PRGS) second-quarter fiscal 2023 results are likely to reflect gains from a strong portfolio that comprises Chef, OpenEdge, DataDirect and Sitefinity solutions.
Cognizant (CTSH) Partners With Accuray to Improve Healthcare
by Zacks Equity Research
Cognizant's (CTSH) partnership agreement will enable Accuray to streamline and drive operational changes to improve patient care.
Cognizant (CTSH) Partners With Orkla to Redefine IT Services
by Zacks Equity Research
Cognizant's (CTSH) partnership-extension agreement will enable Orkla to modernize and improve its IT services.
Cognizant (CTSH) Creates New Group to Expand Into Blue Economy
by Zacks Equity Research
Cognizant (CTSH) forms Cognizant Ocean to expand its services among Blue Economy companies.
Cognizant (CTSH) Accelerates Generative AI Adoption at Scale
by Zacks Equity Research
Cognizant (CTSH) launches Cognizant Neuro AI platform, enabling enterprises to adopt and harness generative AI at scale, reflecting a strong product portfolio and partner base.
5 Stocks That Powered Nasdaq ETF Last Week
by Sweta Killa
The tech-heavy Nasdaq Composite Index managed to end the week in green and move toward yearly highs amid volatile trading.
Cognizant (CTSH) Q1 Earnings Beat Estimates, Revenues Down Y/Y
by Zacks Equity Research
Cognizant's (CTSH) first-quarter 2023 results benefit from strong Health Sciences revenues and acquisitions amid a challenging macro environment.